Co-administration of Anacyclus pyrethrum has shown promise in mitigating withdrawal-related oxidative damage and restoring gut microbiota balance, suggesting potential therapeutic interventions for trihexyphenidyl withdrawal syndrome [92]
If you are considering adding a supplement to your routine while on GLP-1 therapy, consult your doctor or pharmacist first
(Innopeptides) Long-term storage, delivery (penetration into tissues, safety of cell-penetrating segments) are still being worked out
During an average follow-up of 26.3 months (2.2 years, SD 1.9 years), the annual rate of acute healthcare utilization was 1.52 visits/year in the GLP1-RA group and 1.67 visits/year within the DPP4i group (coefficient of regression = 0.15, 95% CI 0.25 to 0.05, p = 0.004)
Autoimmune thyroid disease in specific genetic syndromes in childhood and adolescence